Long-Term Retention of Gadolinium in Bone
Completed · Not applicable
Conditions studied: Focus: Long-term Retention of Gadolinium-based Contrast Agent
In brief
The main objective was to prospectively explore the potential for long-term retention of Gadolinium (Gd) in bones in patients who have received a single dose of Gadolinium-based contrast agents (GBCA) or multiple doses of the same GBCA, with moderate or severe renal impairment or stable normal renal function (eGFR \> 60 ml/min/1.73 m2) at the time of GBCA injection.
Key facts
- Study ID
- NCT01853163
- Run by
- Navitas Life Sciences GmbH
- People needed
- 92
- Starts
- 2013-05-06
- Expected to finish
- 2018-12-17
- Last updated by the study team
- 2022-09-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cedar-Sinai Medical Center — Los Angeles, California, United States
- University Hospital Halle (Saale) — Halle, Germany
- University Hospital Magdeburg — Magdeburg, Germany
- University Hospital Würzburg — Würzburg, Germany
- Fukuoka Orthopaedic Hospital — Fukuoka, Japan
- Nissan Tamagawa Hospital — Tokyo, Japan
- Asan Medical Center Orthopedic Surgery — Seoul, South Korea
- SMG-SNU Boramae Medical Center — Seoul, South Korea
- Hospital Universitario Fundación Alcorcón — Alcorcón, Spain
- Hospital Vall d'Hebron — Barcelona, Spain
- H.G.U. Gregorio Marañón — Madrid, Spain
- Koc University Hospital, Orthopaedics and Traumatology Department — Istanbul, Turkey (Türkiye)
- Acibadem Hospital, Department of Orthopaedics and Traumatology — Istanbul, Turkey (Türkiye)
- Fatih Sultan Mehmet Training and Research Hospital, Department of Orthopedics and Traumatology — Istanbul, Turkey (Türkiye)
- Istanbul Sisli Hamidiye Etfal Egitim ve Arastirma Hastanesi — Istanbul, Turkey (Türkiye)
- Dokuz Eylul University Tıp Faculty — Izmir, Turkey (Türkiye)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.